Share Price and Basic Stock Data
Last Updated: February 24, 2025, 9:26 pm
PEG Ratio | 0.85 |
---|
Competitors of Gujarat Intrux Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Gujarat Intrux Ltd | 142 Cr. | 413 | 647/230 | 14.4 | 179 | 4.11 % | 17.0 % | 12.3 % | 10.0 |
Carnation Industries Ltd | 4.86 Cr. | 14.0 | 14.0/5.97 | 2.75 | 3.44 | 0.00 % | % | % | 10.0 |
Captain Technocast Ltd | 615 Cr. | 530 | 606/146 | 120 | 28.3 | 0.00 % | 19.4 % | 16.9 % | 10.0 |
Nelcast Ltd | 932 Cr. | 107 | 166/96.8 | 36.6 | 61.3 | 0.37 % | 10.1 % | 8.05 % | 2.00 |
Kirloskar Industries Ltd | 3,529 Cr. | 3,389 | 6,699/3,091 | 20.0 | 6,643 | 0.38 % | 10.7 % | 5.40 % | 10.0 |
Industry Average | 5,238.22 Cr | 875.28 | 39.14 | 807.81 | 0.76% | 19.43% | 14.17% | 7.00 |
Quarterly Result
Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 10.69 | 11.38 | 13.81 | 13.15 | 12.94 | 12.55 | 12.80 | 12.89 | 15.35 | 14.08 | 14.88 | 15.59 | 16.40 |
Expenses | 9.41 | 10.32 | 11.90 | 10.80 | 10.92 | 10.18 | 11.22 | 10.75 | 12.08 | 11.66 | 12.55 | 12.20 | 12.94 |
Operating Profit | 1.28 | 1.06 | 1.91 | 2.35 | 2.02 | 2.37 | 1.58 | 2.14 | 3.27 | 2.42 | 2.33 | 3.39 | 3.46 |
OPM % | 11.97% | 9.31% | 13.83% | 17.87% | 15.61% | 18.88% | 12.34% | 16.60% | 21.30% | 17.19% | 15.66% | 21.74% | 21.10% |
Other Income | 0.28 | 0.21 | 0.21 | 0.19 | 0.21 | 0.24 | 0.29 | 0.32 | 0.36 | 0.34 | 0.44 | 0.43 | 0.41 |
Interest | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | -0.00 | 0.01 |
Depreciation | 0.40 | 0.40 | 0.40 | 0.38 | 0.39 | 0.39 | 0.38 | 0.35 | 0.35 | 0.36 | 0.36 | 0.34 | 0.34 |
Profit before tax | 1.13 | 0.84 | 1.71 | 2.14 | 1.83 | 2.21 | 1.47 | 2.10 | 3.27 | 2.39 | 2.40 | 3.48 | 3.52 |
Tax % | 24.78% | 26.19% | 33.92% | 22.43% | 24.04% | 25.79% | 28.57% | 26.19% | 28.13% | 30.96% | 22.08% | 25.29% | 23.30% |
Net Profit | 0.85 | 0.62 | 1.13 | 1.66 | 1.39 | 1.64 | 1.05 | 1.54 | 2.35 | 1.65 | 1.87 | 2.60 | 2.70 |
EPS in Rs | 2.47 | 1.80 | 3.29 | 4.83 | 4.05 | 4.77 | 3.06 | 4.48 | 6.84 | 4.80 | 5.44 | 7.57 | 7.86 |
Last Updated: January 5, 2025, 7:59 am
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 53.71 | 38.29 | 59.71 | 41.58 | 28.78 | 35.28 | 39.77 | 47.87 | 33.71 | 42.46 | 51.43 | 57.19 | 59.90 |
Expenses | 44.62 | 31.27 | 52.80 | 39.86 | 27.05 | 29.95 | 33.30 | 41.07 | 28.03 | 37.39 | 43.12 | 47.04 | 48.49 |
Operating Profit | 9.09 | 7.02 | 6.91 | 1.72 | 1.73 | 5.33 | 6.47 | 6.80 | 5.68 | 5.07 | 8.31 | 10.15 | 11.41 |
OPM % | 16.92% | 18.33% | 11.57% | 4.14% | 6.01% | 15.11% | 16.27% | 14.21% | 16.85% | 11.94% | 16.16% | 17.75% | 19.05% |
Other Income | 0.46 | 0.72 | 0.33 | 0.31 | 0.63 | 0.83 | 0.84 | 0.75 | 0.99 | 0.92 | 0.93 | 1.46 | 1.57 |
Interest | 0.77 | 0.25 | 1.00 | 0.52 | 0.13 | 0.26 | 0.10 | 0.11 | 0.18 | 0.11 | 0.06 | 0.04 | 0.03 |
Depreciation | 0.53 | 0.58 | 1.25 | 0.98 | 0.98 | 1.04 | 1.10 | 1.21 | 1.30 | 1.58 | 1.54 | 1.42 | 1.41 |
Profit before tax | 8.25 | 6.91 | 4.99 | 0.53 | 1.25 | 4.86 | 6.11 | 6.23 | 5.19 | 4.30 | 7.64 | 10.15 | 11.54 |
Tax % | 31.52% | 30.97% | 35.07% | 33.96% | 40.00% | 29.42% | 27.82% | 23.27% | 25.43% | 29.07% | 24.87% | 27.09% | |
Net Profit | 5.65 | 4.77 | 3.24 | 0.35 | 0.74 | 3.43 | 4.41 | 4.78 | 3.87 | 3.05 | 5.74 | 7.41 | 8.47 |
EPS in Rs | 16.28 | 13.89 | 9.43 | 1.02 | 2.15 | 9.98 | 12.84 | 13.91 | 11.27 | 8.88 | 16.71 | 21.57 | 24.65 |
Dividend Payout % | 0.00% | 7.23% | 10.65% | 0.00% | 0.00% | 0.00% | 15.60% | 21.59% | 26.67% | 33.84% | 59.93% | 78.92% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -15.58% | -32.08% | -89.20% | 111.43% | 363.51% | 28.57% | 8.39% | -19.04% | -21.19% | 88.20% | 29.09% |
Change in YoY Net Profit Growth (%) | 0.00% | -16.50% | -57.12% | 200.63% | 252.08% | -334.94% | -20.18% | -27.43% | -2.15% | 109.39% | -59.10% |
Gujarat Intrux Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 8% |
3 Years: | 19% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | 11% |
3 Years: | 24% |
TTM: | 50% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 35% |
3 Years: | 56% |
1 Year: | 56% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 9% |
3 Years: | 10% |
Last Year: | 12% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 2:36 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.45 | 3.45 | 3.45 | 3.45 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 | 3.44 |
Reserves | 25.57 | 29.95 | 32.77 | 33.12 | 33.91 | 37.36 | 41.14 | 45.06 | 47.92 | 49.94 | 54.64 | 58.56 | 58.03 |
Borrowings | 0.00 | 1.27 | 14.17 | 0.00 | 0.47 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Other Liabilities | 6.78 | 9.71 | 8.72 | 4.33 | 3.93 | 3.81 | 7.29 | 5.29 | 4.05 | 5.81 | 4.75 | 8.64 | 8.45 |
Total Liabilities | 35.80 | 44.38 | 59.11 | 40.90 | 41.75 | 44.61 | 51.87 | 53.79 | 55.42 | 59.20 | 62.83 | 70.64 | 69.92 |
Fixed Assets | 8.46 | 9.01 | 9.68 | 9.44 | 10.67 | 11.37 | 12.25 | 13.32 | 17.12 | 15.93 | 14.91 | 13.67 | 13.64 |
CWIP | 0.00 | 0.06 | 0.22 | 1.14 | 0.00 | 0.03 | 0.00 | 0.20 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Assets | 27.34 | 35.31 | 49.21 | 30.32 | 31.08 | 33.21 | 39.62 | 40.27 | 38.30 | 43.24 | 47.92 | 56.97 | 56.28 |
Total Assets | 35.80 | 44.38 | 59.11 | 40.90 | 41.75 | 44.61 | 51.87 | 53.79 | 55.42 | 59.20 | 62.83 | 70.64 | 69.92 |
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 9.09 | 5.75 | -7.26 | 1.72 | 1.26 | 5.33 | 6.47 | 6.80 | 5.67 | 5.06 | 8.31 | 10.15 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 37.17 | 52.14 | 121.22 | 60.39 | 79.77 | 74.80 | 91.78 | 99.66 | 68.43 | 86.14 | 79.91 | 66.76 |
Inventory Days | 89.49 | 195.64 | 169.13 | 140.03 | 214.41 | 203.47 | 200.05 | 127.08 | 155.79 | 188.47 | 138.57 | 164.42 |
Days Payable | 28.77 | 92.71 | 42.99 | 29.11 | 59.28 | 50.50 | 104.39 | 45.14 | 45.79 | 55.36 | 32.84 | 70.10 |
Cash Conversion Cycle | 97.90 | 155.07 | 247.36 | 171.31 | 234.90 | 227.77 | 187.44 | 181.60 | 178.42 | 219.25 | 185.65 | 161.08 |
Working Capital Days | 112.88 | 162.91 | 247.20 | 192.07 | 235.26 | 215.30 | 199.98 | 180.25 | 151.80 | 202.79 | 170.54 | 138.24 |
ROCE % | 33.54% | 22.52% | 14.11% | 2.39% | 3.68% | 13.05% | 14.55% | 13.56% | 10.75% | 8.53% | 13.82% | 16.97% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 21.42 | 16.67 | 8.89 | 11.32 | 13.81 |
Diluted EPS (Rs.) | 21.42 | 16.67 | 8.89 | 11.32 | 13.81 |
Cash EPS (Rs.) | 25.71 | 21.18 | 13.48 | 15.06 | 17.45 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 180.46 | 169.04 | 155.37 | 149.49 | 141.16 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 180.46 | 169.04 | 155.37 | 149.49 | 141.16 |
Dividend / Share (Rs.) | 17.00 | 10.00 | 3.00 | 3.00 | 3.00 |
Revenue From Operations / Share (Rs.) | 166.51 | 149.73 | 123.65 | 98.24 | 139.57 |
PBDIT / Share (Rs.) | 33.80 | 26.90 | 17.44 | 19.41 | 21.98 |
PBIT / Share (Rs.) | 29.67 | 22.43 | 12.83 | 15.62 | 18.45 |
PBT / Share (Rs.) | 29.57 | 22.26 | 12.51 | 15.10 | 18.13 |
Net Profit / Share (Rs.) | 21.58 | 16.70 | 8.87 | 11.27 | 13.91 |
PBDIT Margin (%) | 20.29 | 17.96 | 14.10 | 19.76 | 15.74 |
PBIT Margin (%) | 17.81 | 14.98 | 10.37 | 15.90 | 13.21 |
PBT Margin (%) | 17.75 | 14.86 | 10.11 | 15.37 | 12.99 |
Net Profit Margin (%) | 12.96 | 11.15 | 7.17 | 11.47 | 9.96 |
Return on Networth / Equity (%) | 11.96 | 9.88 | 5.71 | 7.54 | 9.85 |
Return on Capital Employeed (%) | 15.96 | 12.90 | 8.02 | 10.16 | 12.73 |
Return On Assets (%) | 10.49 | 9.13 | 5.15 | 6.98 | 8.88 |
Asset Turnover Ratio (%) | 0.85 | 0.84 | 0.74 | 0.61 | 0.90 |
Current Ratio (X) | 8.29 | 15.08 | 10.04 | 14.42 | 9.89 |
Quick Ratio (X) | 6.20 | 11.60 | 7.11 | 11.77 | 7.62 |
Inventory Turnover Ratio (X) | 2.59 | 2.41 | 2.64 | 1.91 | 2.59 |
Dividend Payout Ratio (NP) (%) | 46.33 | 17.96 | 33.80 | 26.61 | 17.32 |
Dividend Payout Ratio (CP) (%) | 38.89 | 14.16 | 22.24 | 19.91 | 13.82 |
Earning Retention Ratio (%) | 53.67 | 82.04 | 66.20 | 73.39 | 82.68 |
Cash Earning Retention Ratio (%) | 61.11 | 85.84 | 77.76 | 80.09 | 86.18 |
Interest Coverage Ratio (X) | 327.97 | 155.59 | 54.91 | 37.13 | 69.51 |
Interest Coverage Ratio (Post Tax) (X) | 210.46 | 97.60 | 28.94 | 22.56 | 45.00 |
Enterprise Value (Cr.) | 60.87 | 29.55 | 27.63 | 12.93 | 11.59 |
EV / Net Operating Revenue (X) | 1.06 | 0.57 | 0.65 | 0.38 | 0.24 |
EV / EBITDA (X) | 5.24 | 3.20 | 4.61 | 1.94 | 1.53 |
MarketCap / Net Operating Revenue (X) | 1.55 | 0.96 | 1.00 | 1.01 | 0.49 |
Retention Ratios (%) | 53.66 | 82.03 | 66.19 | 73.38 | 82.67 |
Price / BV (X) | 1.43 | 0.85 | 0.79 | 0.66 | 0.48 |
Price / Net Operating Revenue (X) | 1.55 | 0.96 | 1.00 | 1.01 | 0.49 |
EarningsYield | 0.08 | 0.11 | 0.07 | 0.11 | 0.20 |
After reviewing the key financial ratios for Gujarat Intrux Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 21.42. This value is within the healthy range. It has increased from 16.67 (Mar 23) to 21.42, marking an increase of 4.75.
- For Diluted EPS (Rs.), as of Mar 24, the value is 21.42. This value is within the healthy range. It has increased from 16.67 (Mar 23) to 21.42, marking an increase of 4.75.
- For Cash EPS (Rs.), as of Mar 24, the value is 25.71. This value is within the healthy range. It has increased from 21.18 (Mar 23) to 25.71, marking an increase of 4.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 180.46. It has increased from 169.04 (Mar 23) to 180.46, marking an increase of 11.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 180.46. It has increased from 169.04 (Mar 23) to 180.46, marking an increase of 11.42.
- For Dividend / Share (Rs.), as of Mar 24, the value is 17.00. This value exceeds the healthy maximum of 3. It has increased from 10.00 (Mar 23) to 17.00, marking an increase of 7.00.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 166.51. It has increased from 149.73 (Mar 23) to 166.51, marking an increase of 16.78.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 33.80. This value is within the healthy range. It has increased from 26.90 (Mar 23) to 33.80, marking an increase of 6.90.
- For PBIT / Share (Rs.), as of Mar 24, the value is 29.67. This value is within the healthy range. It has increased from 22.43 (Mar 23) to 29.67, marking an increase of 7.24.
- For PBT / Share (Rs.), as of Mar 24, the value is 29.57. This value is within the healthy range. It has increased from 22.26 (Mar 23) to 29.57, marking an increase of 7.31.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 21.58. This value is within the healthy range. It has increased from 16.70 (Mar 23) to 21.58, marking an increase of 4.88.
- For PBDIT Margin (%), as of Mar 24, the value is 20.29. This value is within the healthy range. It has increased from 17.96 (Mar 23) to 20.29, marking an increase of 2.33.
- For PBIT Margin (%), as of Mar 24, the value is 17.81. This value is within the healthy range. It has increased from 14.98 (Mar 23) to 17.81, marking an increase of 2.83.
- For PBT Margin (%), as of Mar 24, the value is 17.75. This value is within the healthy range. It has increased from 14.86 (Mar 23) to 17.75, marking an increase of 2.89.
- For Net Profit Margin (%), as of Mar 24, the value is 12.96. This value exceeds the healthy maximum of 10. It has increased from 11.15 (Mar 23) to 12.96, marking an increase of 1.81.
- For Return on Networth / Equity (%), as of Mar 24, the value is 11.96. This value is below the healthy minimum of 15. It has increased from 9.88 (Mar 23) to 11.96, marking an increase of 2.08.
- For Return on Capital Employeed (%), as of Mar 24, the value is 15.96. This value is within the healthy range. It has increased from 12.90 (Mar 23) to 15.96, marking an increase of 3.06.
- For Return On Assets (%), as of Mar 24, the value is 10.49. This value is within the healthy range. It has increased from 9.13 (Mar 23) to 10.49, marking an increase of 1.36.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has increased from 0.84 (Mar 23) to 0.85, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has decreased from 15.08 (Mar 23) to 8.29, marking a decrease of 6.79.
- For Quick Ratio (X), as of Mar 24, the value is 6.20. This value exceeds the healthy maximum of 2. It has decreased from 11.60 (Mar 23) to 6.20, marking a decrease of 5.40.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.59. This value is below the healthy minimum of 4. It has increased from 2.41 (Mar 23) to 2.59, marking an increase of 0.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 46.33. This value is within the healthy range. It has increased from 17.96 (Mar 23) to 46.33, marking an increase of 28.37.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 38.89. This value is within the healthy range. It has increased from 14.16 (Mar 23) to 38.89, marking an increase of 24.73.
- For Earning Retention Ratio (%), as of Mar 24, the value is 53.67. This value is within the healthy range. It has decreased from 82.04 (Mar 23) to 53.67, marking a decrease of 28.37.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 61.11. This value is within the healthy range. It has decreased from 85.84 (Mar 23) to 61.11, marking a decrease of 24.73.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 327.97. This value is within the healthy range. It has increased from 155.59 (Mar 23) to 327.97, marking an increase of 172.38.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 210.46. This value is within the healthy range. It has increased from 97.60 (Mar 23) to 210.46, marking an increase of 112.86.
- For Enterprise Value (Cr.), as of Mar 24, the value is 60.87. It has increased from 29.55 (Mar 23) to 60.87, marking an increase of 31.32.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.06. This value is within the healthy range. It has increased from 0.57 (Mar 23) to 1.06, marking an increase of 0.49.
- For EV / EBITDA (X), as of Mar 24, the value is 5.24. This value is within the healthy range. It has increased from 3.20 (Mar 23) to 5.24, marking an increase of 2.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.55. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 1.55, marking an increase of 0.59.
- For Retention Ratios (%), as of Mar 24, the value is 53.66. This value is within the healthy range. It has decreased from 82.03 (Mar 23) to 53.66, marking a decrease of 28.37.
- For Price / BV (X), as of Mar 24, the value is 1.43. This value is within the healthy range. It has increased from 0.85 (Mar 23) to 1.43, marking an increase of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.55. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 1.55, marking an increase of 0.59.
- For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to 0.08, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Intrux Ltd:
- Net Profit Margin: 12.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.96% (Industry Average ROCE: 19.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.96% (Industry Average ROE: 14.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 210.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.2
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.4 (Industry average Stock P/E: 39.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.96%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Castings/Foundry | Survey No.84/P, 17 K.M. Rajkot-Gondal Road, Rajkot Dist. Gujarat 360024 | investor@gujaratintrux.com http://www.gujaratintrux.com |
Management | |
---|---|
Name | Position Held |
Mr. Ramankumar D Sabhaya | Chairman & Non-Exe.Director |
Mr. Dhiraj D Pambhar | Managing Director |
Mr. Amrutlal J Kalaria | Non Executive Director |
Mr. Dilipbhai M Dudhagara | Non Executive Director |
Mr. Madhubhai S Patoliya | Non Executive Director |
Mr. Bharatkumar M Dhorda | Non Executive Director |
Mr. Narendrabhai C Pithadia | Independent Director |
Mr. Rameshbhai M Bhimani | Independent Director |
Mr. Gajanan R Kamat | Independent Director |
Mr. Gordhan K Sorthia | Independent Director |
Ms. Rina L Adhiya | Independent Director |
Mr. Niteshkumar P Patel | Independent Director |
FAQ
What is the latest intrinsic value of Gujarat Intrux Ltd?
Let's break down Gujarat Intrux Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 24 February 2025:
- Calculated Fair Value: ₹264.06
- Current Market Price: ₹413.00
- Variance: 36.06% lower
This suggests Gujarat Intrux Ltd is currently overvalued by 36.06%. For context:
- Market Cap: 142 Cr.
- 52-Week Range: 647/230
- Reserves (Sep 2024): ₹58.03 Cr
- Liabilities: 69.92 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of Gujarat Intrux Ltd?
The Market Cap of Gujarat Intrux Ltd is 142 Cr..
What is the current Stock Price of Gujarat Intrux Ltd as on 24 February 2025?
The current stock price of Gujarat Intrux Ltd as on 24 February 2025 is ₹413.
What is the High / Low of Gujarat Intrux Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Gujarat Intrux Ltd stocks is 647/230.
What is the Stock P/E of Gujarat Intrux Ltd?
The Stock P/E of Gujarat Intrux Ltd is 14.4.
What is the Book Value of Gujarat Intrux Ltd?
The Book Value of Gujarat Intrux Ltd is 179.
What is the Dividend Yield of Gujarat Intrux Ltd?
The Dividend Yield of Gujarat Intrux Ltd is 4.11 %.
What is the ROCE of Gujarat Intrux Ltd?
The ROCE of Gujarat Intrux Ltd is 17.0 %.
What is the ROE of Gujarat Intrux Ltd?
The ROE of Gujarat Intrux Ltd is 12.3 %.
What is the Face Value of Gujarat Intrux Ltd?
The Face Value of Gujarat Intrux Ltd is 10.0.